Category: Include on Menu
-
AMD Introduces Helion Agentic AI Rack With Support From Major Technology Partners
Advanced Micro Devices (NASDAQ:AMD) has unveiled AMD Helion, a new rack-scale infrastructure platform designed to support agentic artificial intelligence workloads across hyperscale data centres and enterprise computing environments. Announced on 12 October 2026, the platform provides an open infrastructure blueprint based on an Open Compute Project (OCP) specification design, combining AMD processors, graphics processing units…
-
World Steel Association Cuts 2026 Steel Demand Forecast Amid China Weakness and Middle East Conflict
The World Steel Association has lowered its global steel demand forecasts for 2026 and 2027, citing weaker consumption in China, a slower recovery in European construction and disruptions linked to the US-Israeli war with Iran. The industry organisation now expects worldwide steel demand to decline by 0.1% in 2026, reversing its April projection of 0.3%…
-
Wall Street Futures Flat as Investors Await US Inflation Data and Major Bank Earnings: Dow Jones, S&P, Nasdaq
US stock futures pointed to a broadly unchanged opening on Monday, suggesting a cautious start to trading as investors prepared for important inflation figures and the beginning of a busy corporate earnings period. The subdued outlook followed Friday’s recovery on Wall Street, when the major indices advanced after experiencing selling pressure during the previous session.…
-
First Tracks Biotherapeutics Shares Jump 20% After Positive Phase 1b Celiac Disease Trial Results
First Tracks Biotherapeutics (NASDAQ:TRAX) shares surged 20% on Monday after the biotechnology company reported positive top-line results from a Phase 1b clinical trial evaluating its investigational treatment ANB033 in patients with celiac disease. The study demonstrated statistically significant improvements across key measures of intestinal damage and disease symptoms compared with placebo, supporting further clinical development…
-
DraftKings Faces Pressure as Susquehanna Flags Weak Sports Betting Margins in October
DraftKings (NASDAQ:DKNG) and other US online sports betting operators face potentially weaker revenue performance following unfavourable betting results during the fifth week of the NFL season and sixth week of college football, according to analysis from Susquehanna. The investment firm’s proprietary model indicates that bookmaker hold was unfavourable during the latest reporting week, raising concerns…
-
Contineum Therapeutics Shares Surge 27% After Bristol Myers Squibb Reports Positive Phase 3 Trial Results
Contineum Therapeutics (NASDAQ:CTNM) shares climbed 27% in premarket trading on Monday after Bristol Myers Squibb (NYSE:BMY) reported positive Phase 3 clinical trial results for a pulmonary fibrosis treatment targeting the same biological pathway as Contineum’s lead drug candidate. Contineum shares were indicated at $16.99 before the market opened, compared with Friday’s closing price of $13.38,…
-
Microchip Technology Expands Data Centre Portfolio With New PCIe, NVMe and RAID Solutions
Microchip Technology (NASDAQ:MCHP) has announced an expansion of its data centre technology portfolio, introducing new connectivity, storage controller and acceleration products designed to support increasingly complex computing infrastructure. In an announcement dated 12 October 2026, the semiconductor company outlined enhancements across its Switchtec PCIe, Flashtec NVMe and Adaptec SmartRAID product families, targeting improvements in data…
-
Bristol Myers Squibb Shares Jump 6.5% Following Positive Phase 3 Trial Results for Two Therapies
Bristol Myers Squibb (NYSE:BMY) shares rose 6.5% on Monday after the pharmaceutical company announced positive results from two Phase 3 clinical trials evaluating treatments for neuroendocrine tumours and idiopathic pulmonary fibrosis. The results involved RYZ101, an investigational radiopharmaceutical therapy for gastroenteropancreatic neuroendocrine tumours, and admilparant, an experimental treatment for idiopathic pulmonary fibrosis. Both studies met…
-
Jiuzi Holdings Announces $50 Million Investment Commitment at Minimum Price of $2.50 Per Share
Jiuzi Holdings, Inc. (NASDAQ:JZXN) has announced that a strategic investor has committed to investing at least $50 million in the company at a minimum price of $2.50 per ordinary share, subject to the finalisation of transaction arrangements and regulatory requirements. The Nasdaq-listed company said the proposed investment could provide additional capital to support its operations…
-
Enovix Q3 Revenue Rises 38% to $11 Million, Exceeding Guidance as Defence Demand Grows
Enovix Corporation (NASDAQ:ENVX) reported preliminary third-quarter fiscal 2026 revenue of approximately $11.0 million, exceeding its previous guidance as demand from drone and defence customers supported growth. The battery technology company said revenue increased 38% year on year and came in 10% above the upper end of its guidance range of $9.0 million to $10.0 million.…